Shares in Clough family-backed NeuroScientific Biopharmaceuticals have plunged after a planned clinical trial for its budding Alzheimer's treatment was rejected by the Human Research Ethics Committee.
One of Western Australia's most successful engineers, business leaders and philanthropists has passed away at the age of 95. True to form, he was at his desk just two days ago.
Nedlands-based NeuroScientific Biopharmaceuticals, which has been bankrolled by the Clough family, is set to begin trading on the ASX tomorrow, after raising $6 million via an initial public offering.
Global waste management group Suez has paid $87 million for local company Perthwaste, which has experienced rapid growth in recent years with backing from WA business leader Harold Clough.